With a blood pressure of 80/60 mmHg and a mean arterial pressure of 66 mmHg, should I increase the inotrope infusion?

Yes, escalate inotropes immediately

With a MAP of 66 mmHg and systolic BP of 80 mmHg, you should increase inotrope support now, as this patient is in hypotensive shock requiring urgent hemodynamic optimization to prevent end-organ damage.

Clinical Context and Urgency

Your patient meets criteria for cardiogenic shock with:

• SBP <90 mmHg (80 mmHg in this case)
• MAP 66 mmHg (just at the minimum threshold)
• Presumed signs of hypoperfusion (given inotrope use)

The ESC guidelines define cardiogenic shock as SBP <90 mmHg with signs of hypoperfusion, and recommend inotropes for patients with severe reduction in cardiac output resulting in compromised vital organ perfusion 1. Your patient is already on inotropes but remains hypotensive, indicating inadequate current support.

Target Blood Pressure

Aim for MAP ≥70 mmHg as your immediate goal:

• Recent evidence from the DOREMI trial shows that achieving MAP ≥70 mmHg in cardiogenic shock patients is associated with significantly better outcomes (mortality 28.9% vs 57.8% when MAP <70 mmHg) 2
• The standard MAP target of ≥65 mmHg used in septic shock may be insufficient for cardiogenic shock patients 3, 4
• Failure to achieve MAP ≥65 mmHg within 60 minutes is independently associated with increased ICU mortality 5

Escalation Strategy

Step 1: Assess Current Hemodynamics

Before escalating, quickly verify:

• Volume status: Ensure adequate preload (avoid inotropes if hypovolemic) 1
• Signs of hypoperfusion: Cool extremities, altered mentation, urine output <30 mL/h, lactate >2 mmol/L 6, 7
• Cardiac output adequacy: If available, check if CI <1.8-2.2 L/min/m² 8

Step 2: Choose Your Agent Based on Clinical Profile

If predominantly low cardiac output (cold extremities, poor perfusion):

• Increase dobutamine (current first-line inotrope): Titrate from 2.5 μg/kg/min up to 10-20 μg/kg/min 1
• Consider levosimendan if patient is on beta-blockers (0.1 μg/kg/min, can adjust 0.05-0.2 μg/kg/min), though avoid if SBP <85 mmHg 1

If MAP remains <65-70 mmHg despite inotrope escalation:

• Add norepinephrine as first-line vasopressor (start 0.05-0.1 μg/kg/min, titrate to effect) 6, 1, 3, 4, 9
• Norepinephrine is preferred over dopamine (lower mortality, fewer arrhythmias) 1
• Higher initial norepinephrine doses (0.1 μg/kg/min) achieve MAP targets faster than lower doses (0.025-0.05 μg/kg/min) when baseline MAP is severely depressed 5

Step 3: Monitoring During Escalation

Essential monitoring:

• Continuous ECG (watch for tachycardia, ischemia, arrhythmias) 1, 10
• MAP every 1-5 minutes initially, then every 15 minutes once stable
• Clinical perfusion markers: mental status, skin temperature, urine output
• Lactate levels and acid-base status 6, 8
• Consider arterial line for continuous BP monitoring 1, 10

Critical Pitfalls to Avoid

1. Don't delay escalation: Prolonged hypotension (MAP <65 mmHg >60 minutes) worsens outcomes 5

2. Don't use inotropes alone if vasopressor is needed: If MAP remains low despite inotrope escalation, you need vasoconstriction (norepinephrine), not just more inotropy 1, 4

3. Avoid excessive inotrope doses in normotensive patients: Inotropes in patients with SBP ≥90 mmHg are associated with worse outcomes 11. However, your patient is hypotensive, so this doesn't apply.

4. Don't combine multiple inotropes: Rather than stacking dobutamine + milrinone, consider mechanical circulatory support if single-agent inotrope + vasopressor fails 6

5. Watch for tachyarrhythmias: Inotropes (especially high-dose dobutamine, dopamine) increase risk of ischemia and arrhythmias 1

When to Consider Mechanical Support

If escalating inotropes + vasopressors fail to achieve MAP ≥70 mmHg and adequate perfusion within 30-60 minutes, strongly consider:

• IABP (though not routinely recommended, may help in specific cases) 6
• Percutaneous mechanical circulatory support (Impella, VA-ECMO) for refractory shock 6, 3, 12
• Transfer to advanced heart failure center if not already there 6, 13

Bottom Line Algorithm

1. Verify volume status (give fluid challenge if hypovolemic)
2. Increase dobutamine to 10-20 μg/kg/min
3. Add norepinephrine 0.05-0.1 μg/kg/min if MAP <70 mmHg persists
4. Titrate to MAP ≥70 mmHg with continuous monitoring
5. Reassess at 30-60 minutes: If still unstable, consider mechanical support

Your patient's MAP of 66 mmHg is borderline but combined with SBP 80 mmHg indicates inadequate perfusion pressure—act now to prevent irreversible organ injury.